The Company has identified four areas that are the core of its business strategy. With a focus on projects that strive to bring technology and health solutions together, the Company is pursuing multiple projects that fit into this development philosophy.
- Molecular Biology
- Genetic Selection
- Nutraceutical Solutions
- Autonomous Medical Care
The Company is investigating the impact of increasing the bio-availability of nutraceutical based protocols through the enhancement of molecular structures or delivery systems. Read More
The Company is researching work projects that are focussed on creating a homogenous library of plants through the study and augmentation of the plants core genetics.
The Company is investigating the health effects of various natural remedies on the health of consumers either alone or in conjunction with other elements.
In focus are various plant based products that are targeted to relieve symptoms such as:
- Chronic inflammation
- High Cholesterol
Autonomous Medical Care
The Company offers Automated Biomedical Care (ABC) services for common health problems. The company has an extensive platform for electro-physiologically interactive computing (EPIC) supporting therapeutic-diagnostic (theranostic) devices, expert systems, and recommender applications for personal health management.
The markets for people with cardio-metabolic conditions seeking to normalize blood pressure, blood glucose levels, BMI (weight) management and skin conditions such as acne are in the multi-billions.
Monitoring schedules, measurement procedures, and conditioning protocols are prescribed automatically.
The online system is aimed primarily at “practicing patients” interested in normalizing blood pressure, blood glucose, and body weight.
*FAST – short for Fully Automated Signal Transduction